EQUITY |
9 Months Ended | 12 Months Ended |
|---|---|---|
Sep. 30, 2025 |
Dec. 31, 2024 |
|
| Equity [Abstract] | ||
| EQUITY | NOTE 5 – EQUITY
Common stock
The Company has authorized shares of Common Stock and shares of Preferred Stock both with a par value of $. As of September 30, 2025, and December 31, 2024, there were and shares of Common Stock issued and outstanding, respectively.
Series A Preferred Stock
As of September 30, 2025 and December 31, 2024 there were 500,000 Series A Preferred Shares outstanding which carried super voting rights of 21,000,000,000 common shares. Each share of Preferred A is convertible into 250 shares of common stock.
|
NOTE 5 – EQUITY
Common stock
The Company has authorized shares of Common Stock and shares of Preferred Stock both with a par value of $. As of December 31, 2024 and December 31, 2023, there were and shares of Common Stock issued and outstanding, respectively.
Series A Preferred Stock
As of December 31, 2024 and December 31, 2023 there were 500,000 Series A Preferred Shares outstanding which carried super voting rights of 21,000,000,000 common shares. Each share of Preferred A is convertible into 250 shares of common stock.
|